Phase 1 Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 40 years of age or older, of any gender
- You have been diagnosed with, or are suspected to have, a lung scarring condition called ILD (specifically IPF or CTD-ILD), confirmed by a type of chest scan (CT scan)
- Your lung function tests show your lungs are working at least 40% of expected capacity for two key measurements, and your breathing airways are not significantly narrowed (confirm with trial site if unsure about your results)
- You are able to undergo a procedure called a bronchoscopy, where a thin tube is passed into your airways to examine your lungs
- You are willing to use effective birth control throughout the study period
- You are able to use an inhaler device correctly
Who may not be able to join:
- You are currently pregnant or breastfeeding
- You have a known allergy to any ingredient in the study medication
- You currently have an active chest or breathing infection, or a serious heart or lung condition that has recently become worse
- Your liver function blood tests show results that are above the normal range
- You have smoked within the last 6 months, or you have issues with excessive alcohol use
- You have taken part in another clinical trial within the last 3 months
- You have donated 400mL or more of blood within the last 3 months
- You have certain levels of hepatitis B, hepatitis C, or you are HIV positive (confirm specific threshold details with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
AUC0-24 hours of blood samples in ILD patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.